Women under 30 not recognizing signs of cervical cancer
the ONA take:
According to research published in the British Journal of General Practice, many women under 30 years of age do not recognize the symptoms of cervical cancer, and therefore, are diagnosed more than 3 months after first developing symptoms of the disease. For the study, researchers from King's College London in London, United Kingdom, interviewed 128 women under the age of 30 with newly diagnosed cervical cancer.
Of those, 86 had been diagnosed during a routine screening, 40 had been diagnosed after visiting a doctor because of symptoms, and 2 were diagnosed while being treated for an unrelated condition.
Of the 40 women diagnosed after visiting a doctor because of their symptoms, most women reported experiencing bleeding after intercourse or between periods. In addition, 11 of the 40 women had waited over 3 months to see a doctor, and 10 of those were not aware of the signs and symptoms of cervical cancer. Researchers also found that women under 25 were more likely to delay seeking treatment compared with women aged between 25 and 29.
Researchers suggest that women under 25 should be educated of the possible symptoms associated with cervical cancer, such as persistent vaginal discharge or bleeding after intercourse or between periods.
Many women under 30 years of age do not recognize the symptoms of cervical cancer.
New research led by King's College London suggests that many women under 30 with cervical cancer are diagnosed more than 3 months after first having symptoms. In many cases this was because they did not recognise the symptoms as serious.
The study is published today in the British Journal of General Practice. Approximately 1 in 134 women will get cervical cancer at some point in their lives. It is most common in women in their thirties. Cervical cancer is nearly always caused by the Human Papillomavirus (HPV).
HPV infection is very common, especially in young women, but for most, the infection resolves completely on its own and does not lead to cervical cancer. In England, the NHS offers screening to prevent cervical cancer to women aged 25-64.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|